phorbolol myristate acetate has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ibrahim, S; Levin, B; Meruelo, D; Pellicer, A; Suzme, R; Tseng, JC | 1 |
Chen, L; Jin, X; Li, H; Mao, J; Wang, L; Xu, B; Yuan, J; Zhang, H; Zhu, J | 1 |
2 other study(ies) available for phorbolol myristate acetate and Metastase
Article | Year |
---|---|
Sindbis viral vectors target hematopoietic malignant cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Hematologic Neoplasms; Humans; Injections, Intraperitoneal; Jurkat Cells; Male; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Transgenic; Neoplasm Metastasis; Neoplasms, Experimental; Oncolytic Virotherapy; Receptors, Laminin; Sindbis Virus; Tetradecanoylphorbol Acetate | 2012 |
Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Size; Chloride Channels; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Interfering; Tamoxifen; Tetradecanoylphorbol Acetate | 2013 |